Skip to main content
Clinical Trials/KCT0007619
KCT0007619
Not yet recruiting
未知

The clinical trial to evaluate the correlation between treatment efficiency of SGLT-2 inhibitor and dietary habits changes in patients with type 2 diabetes: a prospective observational pilot study

Kangbuk Samsung Medical Center0 sites46 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Endocrine, nutritional and metabolic diseases
Sponsor
Kangbuk Samsung Medical Center
Enrollment
46
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? Type 2 diabetes
  • ? Between 19 and 70 years of age
  • ? HbA1c \>7\.0%
  • ? Patients without stable drug treatment or drug treatment history for more than 3 months.
  • ? Subjects who have understood the contents of the clinical trial and voluntarily consented in writing
  • ? Can write a diary well and agree to it

Exclusion Criteria

  • ?Patients with a history of prescribing SGLT\-2 inhibitors within 3 months
  • ?Patients with a history of taking an appetite suppressant or GLP\-1 agonist within 3 months
  • ?Anemia (hemoglobin outside the normal range)
  • ?People with a form of gastrointestinal disease that can affect appetite changes
  • ?Liver disease (Alanine Aminotransferase, ALAT) and/or serum aspartaaminotransferase (ASAT) \> 2 times normal) or history of liver disease
  • ?Renal disease eGFR by MDRD equation less than 45 mL/min/1\.73 m2
  • ?Anorexia, bulimia, or bulimia
  • ?When the investigator determines that physical or psychological circumstances may prevent participation in the trial

Outcomes

Primary Outcomes

Not specified

Similar Trials